These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer. Mahler C; Verhelst J; Denis L Clin Pharmacokinet; 1998 May; 34(5):405-17. PubMed ID: 9592622 [TBL] [Abstract][Full Text] [Related]
4. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy. Migliari R; Muscas G; Murru M; Verdacchi T; De Benedetto G; De Angelis M Arch Ital Urol Androl; 1999 Dec; 71(5):293-302. PubMed ID: 10673793 [TBL] [Abstract][Full Text] [Related]
5. [Application of antiandrogens on prostatic diseases]. Takahashi S; Hasegawa F; Isurugi K Nihon Rinsho; 1994 Mar; 52(3):809-14. PubMed ID: 7513031 [TBL] [Abstract][Full Text] [Related]
6. Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma. Schröder FH Prog Clin Biol Res; 1990; 359():93-103; discussion 105-7. PubMed ID: 2149460 [TBL] [Abstract][Full Text] [Related]
7. Antiandrogens in the treatment of prostate cancer. Wirth MP; Hakenberg OW; Froehner M Eur Urol; 2007 Feb; 51(2):306-13; discussion 314. PubMed ID: 17007995 [TBL] [Abstract][Full Text] [Related]
8. Endocrine therapy for prostate cancer. Damber JE Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920 [TBL] [Abstract][Full Text] [Related]
9. Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens. Crawford ED; Schellhammer PF; McLeod DG; Moul JW; Higano CS; Shore N; Denis L; Iversen P; Eisenberger MA; Labrie F J Urol; 2018 Nov; 200(5):956-966. PubMed ID: 29730201 [TBL] [Abstract][Full Text] [Related]
10. Antiandrogenic agents as monotherapy in advanced prostatic carcinoma. Soloway MS; Matzkin H Cancer; 1993 Feb; 71(3 Suppl):1083-8. PubMed ID: 8428332 [TBL] [Abstract][Full Text] [Related]
11. Carcinoma of the prostate. Guidelines for treatment: the role of antiandrogens. Pavone-Macaluso M; Cacciatore M; Daricello G; Pavone C; Serretta V Ann N Y Acad Sci; 1990; 595():328-33. PubMed ID: 2375611 [TBL] [Abstract][Full Text] [Related]
12. What implications do the tolerability profiles of antiandrogens and other commonly used prostate cancer treatments have on patient care? Mason M J Cancer Res Clin Oncol; 2006 Aug; 132 Suppl 1():S27-35. PubMed ID: 16896883 [TBL] [Abstract][Full Text] [Related]
13. Antiandrogen treatments in locally advanced prostate cancer: are they all the same? Gillatt D J Cancer Res Clin Oncol; 2006 Aug; 132 Suppl 1():S17-26. PubMed ID: 16845534 [TBL] [Abstract][Full Text] [Related]
14. Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project. Decensi AU; Boccardo F; Guarneri D; Positano N; Paoletti MC; Costantini M; Martorana G; Giuliani L J Urol; 1991 Aug; 146(2):377-81. PubMed ID: 1856935 [TBL] [Abstract][Full Text] [Related]
15. Hormone therapy of advanced prostate cancer: where we stand today. Crawford ED; Nabors W Oncology (Williston Park); 1991 Jan; 5(1):21-30; discussion 30, 32, 37. PubMed ID: 1828686 [TBL] [Abstract][Full Text] [Related]
16. Clinical profile of a new non-steroidal antiandrogen. Mahler C; Denis L J Steroid Biochem Mol Biol; 1990 Dec; 37(6):921-4. PubMed ID: 2126736 [TBL] [Abstract][Full Text] [Related]
17. [Fundamental and clinical study on antiandrogens--androgen-dependency of prostatic tumors and clinical application of antiandrogens (author's transl)]. Shida K Horumon To Rinsho; 1980 Aug; 28(8):899-928. PubMed ID: 6161722 [No Abstract] [Full Text] [Related]
18. Pharmacology and clinical use of antiandrogens: a short review. Neumann F Ir J Med Sci; 1982 Mar; 151(3):61-70. PubMed ID: 7042638 [No Abstract] [Full Text] [Related]